Using systematic in vitro and in vivo experiments, it was revealed that SNX10 impacted B-ALL proliferation, apoptosis and migration by modulating the PI3K/Akt signaling pathway. Here, AKT1 is linked to precursor B-cell acute lymphoblastic leukemia.